250 related articles for article (PubMed ID: 28166647)
1. Building trust and diversity in patient-centered oncology clinical trials: An integrated model.
Hurd TC; Kaplan CD; Cook ED; Chilton JA; Lytton JS; Hawk ET; Jones LA
Clin Trials; 2017 Apr; 14(2):170-179. PubMed ID: 28166647
[TBL] [Abstract][Full Text] [Related]
2. Ambivalence: A Key to Clinical Trial Participation?
Chilton JA; Rasmus ML; Lytton J; Kaplan CD; Jones LA; Hurd TC
Front Oncol; 2018; 8():300. PubMed ID: 30148115
[TBL] [Abstract][Full Text] [Related]
3. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
4. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
5. Design of a cluster-randomized minority recruitment trial: RECRUIT.
Tilley BC; Mainous AG; Smith DW; McKee MD; Amorrortu RP; Alvidrez J; Diaz V; Ford ME; Fernandez ME; Hauser RA; Singer C; Landa V; Trevino A; DeSantis SM; Zhang Y; Daniels E; Tabor D; Vernon SW
Clin Trials; 2017 Jun; 14(3):286-298. PubMed ID: 28545336
[TBL] [Abstract][Full Text] [Related]
6. Barriers and facilitators to participation of minorities in clinical trials.
Schmotzer GL
Ethn Dis; 2012; 22(2):226-30. PubMed ID: 22764647
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of racial and ethnic minorities to clinical trials conducted within specialty clinics: an intervention mapping approach.
Amorrortu RP; Arevalo M; Vernon SW; Mainous AG; Diaz V; McKee MD; Ford ME; Tilley BC
Trials; 2018 Feb; 19(1):115. PubMed ID: 29454389
[TBL] [Abstract][Full Text] [Related]
8. Introduction to the science of recruitment and retention among ethnically diverse populations.
Dilworth-Anderson P
Gerontologist; 2011 Jun; 51 Suppl 1(Suppl 1):S1-4. PubMed ID: 21565811
[TBL] [Abstract][Full Text] [Related]
9. Strategies for research participant engagement: A synthetic review and conceptual framework.
Wong CA; Song WB; Jiao M; O'Brien E; Ubel P; Wang G; Scales CD
Clin Trials; 2021 Aug; 18(4):457-465. PubMed ID: 34011179
[TBL] [Abstract][Full Text] [Related]
10. Views on clinical trial recruitment, biospecimen collection, and cancer research: population science from landscapes of the Haudenosaunee (People of the Longhouse).
Haring RC; Henry WA; Hudson M; Rodriguez EM; Taualii M
J Cancer Educ; 2018 Feb; 33(1):44-51. PubMed ID: 27392418
[TBL] [Abstract][Full Text] [Related]
11. Patient-centered boundary mechanisms to foster intercultural partnerships in health care: a case study in Guatemala.
Hitziger M; Berger Gonzalez M; Gharzouzi E; Ochaíta Santizo D; Solis Miranda R; Aguilar Ferro AI; Vides-Porras A; Heinrich M; Edwards P; Krütli P
J Ethnobiol Ethnomed; 2017 Aug; 13(1):44. PubMed ID: 28789670
[TBL] [Abstract][Full Text] [Related]
12. A nurse's primer on recruiting participants for clinical trials.
Barrett R
Oncol Nurs Forum; 2002 Aug; 29(7):1091-8. PubMed ID: 12183757
[TBL] [Abstract][Full Text] [Related]
13. Practical steps to community engaged research: from inputs to outcomes.
Isler MR; Corbie-Smith G
J Law Med Ethics; 2012; 40(4):904-14. PubMed ID: 23289693
[TBL] [Abstract][Full Text] [Related]
14. The process of clinical trials: a model for successful clinical trial participation.
Lengacher CA; Gonzalez LL; Giuliano R; Bennett MP; Cox CE; Reintgen DS
Oncol Nurs Forum; 2001 Aug; 28(7):1115-20. PubMed ID: 11517845
[TBL] [Abstract][Full Text] [Related]
15. Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process.
Witham MD; Anderson E; Carroll C; Dark PM; Down K; Hall AS; Knee J; Maier RH; Mountain GA; Nestor G; Oliva L; Prowse SR; Tortice A; Wason J; Rochester L;
Trials; 2020 Aug; 21(1):694. PubMed ID: 32738919
[TBL] [Abstract][Full Text] [Related]
16. "We are not invited": Australian focus group results on how to improve ethnic diversity in trials.
Brijnath B; Muoio R; Feldman P; Ghersi D; Chan AW; Welch V; Treweek S; Green H; Orkin AM; Owusu-Addo E
J Clin Epidemiol; 2024 Jun; 170():111366. PubMed ID: 38631530
[TBL] [Abstract][Full Text] [Related]
17. Beyond diversity to inclusion: recruitment and retention of diverse groups in Alzheimer research.
Dilworth-Anderson P; Cohen MD
Alzheimer Dis Assoc Disord; 2010; 24 Suppl():S14-18. PubMed ID: 22720319
[TBL] [Abstract][Full Text] [Related]
18. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
19. Why do - or don't - patients with urinary tract infection participate in a clinical trial? A qualitative study in German family medicine.
Bleidorn J; Bucak S; Gágyor I; Hummers-Pradier E; Dierks ML
Ger Med Sci; 2015; 13():Doc17. PubMed ID: 26512232
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
